Aligned Genetics, Inc. (KOSDAQ: 238120)

Aligned Genetics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	13,512	14,927	10,696	6,137	5,639	4,898
Short-Term Investments	2,600	-	3,000	7,000	6,500	9,001
Cash & Short-Term Investments	16,112	14,927	13,696	13,137	12,139	13,899
Cash Growth	22.58%	8.99%	4.25%	8.22%	-12.66%	0.33%
Accounts Receivable	2,230	2,667	1,451	2,130	1,274	984.04
Other Receivables	134.31	55.64	17.55	293.91	219.34	174.84
Receivables	2,364	2,723	1,469	2,424	1,494	1,159
Inventory	4,686	3,852	3,759	2,353	2,110	2,120
Prepaid Expenses	173.91	13.01	343.11	58.1	70.99	79.16
Other Current Assets	119.73	88.1	284.98	413.05	128.57	37.39
Total Current Assets	23,456	21,603	19,552	18,386	15,942	17,294
Property, Plant & Equipment	7,865	8,035	7,285	5,776	1,673	2,039
Long-Term Investments	8,538	8,584	7,233	7,744	6,986	4,321
Other Intangible Assets	17	31.03	64.35	101.08	152.42	208.49
Long-Term Deferred Tax Assets	1,849	2,064	2,043	1,780	-	-
Long-Term Deferred Charges	-	-	-	0	71.52	166.2
Other Long-Term Assets	855.71	615.37	723.89	683.35	656.94	590.61
Total Assets	42,580	40,932	36,901	34,469	25,481	24,619
Accounts Payable	123.64	164.9	134.26	144.46	278.44	157.4
Accrued Expenses	43.94	130.05	277.79	150.37	143.95	138.57
Current Portion of Long-Term Debt	3,900	3,900	-	-	-	-
Current Portion of Leases	175.47	175.47	235.32	214.76	211.59	286.43
Current Income Taxes Payable	73.15	77.4	87.32	-	-	-
Current Unearned Revenue	-	9.86	-	-	-	-
Other Current Liabilities	920.32	780.35	598.52	907.73	585.46	318.84
Total Current Liabilities	5,237	5,238	1,333	1,417	1,219	901.23
Long-Term Debt	-	-	3,900	3,900	-	-
Long-Term Leases	488.94	587.61	243.97	320.97	916.77	994.02
Other Long-Term Liabilities	341.57	284.31	152.49	98.52	270.52	349.39
Total Liabilities	9,837	9,620	8,052	7,477	4,017	3,653
Common Stock	7,189	7,189	3,595	3,595	3,595	1,797
Additional Paid-In Capital	22,646	22,646	26,259	26,259	26,259	28,056
Retained Earnings	2,928	1,680	-1,202	-2,936	-8,449	-8,903
Comprensive Income & Other	-19.44	-203.85	197.9	74.85	59.14	16.23
Shareholders' Equity	32,744	31,311	28,850	26,992	21,464	20,967
Total Liabilities & Equity	42,580	40,932	36,901	34,469	25,481	24,619
Total Debt	4,564	4,663	4,379	4,436	1,128	1,280
Net Cash (Debt)	11,548	10,264	9,317	8,701	11,010	12,619
Net Cash Growth	30.29%	10.17%	7.07%	-20.97%	-12.74%	-8.91%
Net Cash Per Share	803.12	713.81	647.93	605.15	1058.68	877.57
Filing Date Shares Outstanding	14.38	14.38	14.38	14.38	14.38	14.38
Total Common Shares Outstanding	14.38	14.38	14.38	14.38	14.38	14.38
Working Capital	18,220	16,365	18,219	16,968	14,722	16,393
Book Value Per Share	2277.20	2177.60	2006.39	1877.21	1492.72	1458.14
Tangible Book Value	32,727	31,280	28,785	26,891	21,311	20,758
Tangible Book Value Per Share	2276.02	2175.44	2001.92	1870.18	1482.12	1443.64
Land	1,557	-	-	1,557	-	-
Buildings	2,974	-	-	2,974	-	-
Machinery	2,661	-	-	2,001	1,780	1,664

Source: S&P Capital IQ. Standard template. Financial Sources.